The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

Pluribus season one has ended. As the wait for season two of the Apple TV series begins, newly minted fans of lead actor Rhea Seehorn are discovering something fans of her work on Better Call Saul ...

Forbes contributors publish independent expert analyses and insights. I’m a founder, writer and lecturer focusing on VC funds. BEIJING, CHINA - SEPTEMBER 24: A technician works in a lab at Sinovac ...

The link between Alzheimer’s disease and amyloid plaques is well documented, with innumerable studies exploring techniques and therapies to inhibit plaque formation, preventing development or ...

Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer's disease and preserves cognitive function ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

The familiar ritual of online shopping, scrolling through endless search results, comparing tabs and filling digital carts is on the verge of obsolescence. AI agents are now entering the marketplace ...

A new study has revealed that TSPO, a protein linked to brain inflammation, rises long before Alzheimer’s symptoms appear. Researchers tracked the protein in genetically engineered mice and confirmed ...

Journal Editorial Report: The Fed Chief signals rate cuts are coming. As we saw during the Covid pandemic, lab-created experiments can wreak havoc when they escape their confines. Once released, they ...

What if your Excel spreadsheet could think for you? Imagine typing a simple prompt like “Summarize sales trends by region” and watching as your data transforms into actionable insights, no formulas, ...

Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School ...